Blood Glucose
Dopamine Receptor Agonist
Bile Acid Sequestrant
Glinides
Assessment of the Treatment Regimen
Treatment Algorithm
Adverse Effects During Statin Therapy
Body fat, metabolic changes before pancreatic cancer diagnosis may aid in early detection
In the 36 months prior to diagnosis of pancreatic ductal adenocarcinoma, researchers observed “predominant changes” in patients’ body composition and biochemical markers, which may serve as potential biomarkers for early cancer detection.
FDA: Avoid using smartwatches, smart rings to measure blood glucose
The FDA is warning people with diabetes and the public that noninvasive smartwatches or smart rings that do not pierce the skin should not be used to measure blood glucose, according to a press release.
Glucose-lowering therapies linked to reduced risk for CV events in type 2 diabetes, MASLD
Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists were associated with lower risk for cardiovascular events in type 2 diabetes, with or without metabolic dysfunction-associated steatotic liver disease.
Increased preoperative blood glucose level associated with PJI after THA
Results showed a preoperative blood glucose level greater than 277 mg/dL in patients with diabetes and greater than 193 mg/dL in patients without diabetes was associated with an increased risk of infection after total hip arthroplasty.